When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 Years.

Saved in:
Bibliographic Details
Title: When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 Years.
Authors: Cánovas R; Australian E-Health Research Centre, CSIRO, Parkville, Australia., Cox T; Australian E-Health Research Centre, CSIRO, Canberra, Australia., Doré V; Australian E-Health Research Centre, CSIRO, Parkville, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Australia., Bourgeat P; Australian E-Health Research Centre, CSIRO, Herston, Australia., Fripp J; Australian E-Health Research Centre, CSIRO, Herston, Australia., Feizpour A; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Australia.; The Florey Institute, University of Melbourne, Parkville, Australia., Shishegar R; Australian E-Health Research Centre, CSIRO, Parkville, Australia., Fowler CJ; The Florey Institute, University of Melbourne, Parkville, Australia., Laws SM; Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.; Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.; Curtin Medical School, Curtin University, Bentley, Australia., Porter T; Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.; Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.; Curtin Medical School, Curtin University, Bentley, Australia., Rainey-Smith S; Centre for Healthy Ageing, Murdoch University, Murdoch, Australia.; Australian Alzheimer's Research Foundation, Perth, Australia.; University of Western Australia, Perth, Australia.; Edith Cowan University, School of Medical and Health Sciences, Centre of Excellence for Alzheimer's Disease Research and Care, Joondalup, Australia., Shaw LM; Department of Pathology and Lab Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Bateman RJ; Department of Neurology, Washington University School of Medicine, St. Louis, MO.; Tracy Family SILQ Center for Neurodegenerative Biology, St. Louis, MO.; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, St. Louis, MO., Li Y; Department of Neurology, Washington University School of Medicine, St. Louis, MO., Vitaliy O; Department of Neurology, Washington University School of Medicine, St. Louis, MO.; Tracy Family SILQ Center for Neurodegenerative Biology, St. Louis, MO., Weiner MW; Department of Radiology, University of California, San Francisco, San Francisco, CA., Morris JC; Department of Neurology, Washington University School of Medicine, St. Louis, MO.; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, St. Louis, MO., Benzinger TLS; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, St. Louis, MO.; Department of Radiology, University of California, San Francisco, San Francisco, CA., Schindler SE; Department of Neurology, Washington University School of Medicine, St. Louis, MO.; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, St. Louis, MO., Nakamura A; Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan., Iwatsubo T; Department of Neuropathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.; National Center of Neurology and Psychiatry, Tokyo, Japan., Ikeuchi T; Department of Molecular Genetics Brain Research Institute, Niigata University, Niigata, Japan., Kato T; National Hospital for Geriatric Medicine, National Centre for Geriatrics and Gerontology, Obu, Japan., Maruff P; The Florey Institute, University of Melbourne, Parkville, Australia.; Cogstate, Melbourne, Australia., Sohrabi HR; Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.; School of Psychology, Murdoch University, Murdoch, Australia., Rowe CC; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Australia.; The Florey Institute, University of Melbourne, Parkville, Australia., Martins RN; Australian Alzheimer's Research Foundation, Perth, Australia.; Macquarie University, Department of Biological Sciences, North Ryde, Australia., Masters CL; The Florey Institute, University of Melbourne, Parkville, Australia., Doecke JD; Australian E-Health Research Centre, CSIRO, Herston, Australia.; Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
Corporate Authors: Alzheimer's Disease Neuroimaging Initiative
Source: Annals of neurology [Ann Neurol] 2026 May; Vol. 99 (5), pp. 1327-1342. Date of Electronic Publication: 2026 Jan 26.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-8249
DOI:10.1002/ana.78163